11-48306227-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004725.1(OR4S1):c.5G>A(p.Gly2Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000941 in 1,593,986 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004725.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4S1 | NM_001004725.1 | c.5G>A | p.Gly2Asp | missense_variant | 1/1 | ENST00000319988.1 | NP_001004725.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4S1 | ENST00000319988.1 | c.5G>A | p.Gly2Asp | missense_variant | 1/1 | 6 | NM_001004725.1 | ENSP00000321447.1 |
Frequencies
GnomAD3 genomes AF: 0.0000137 AC: 2AN: 145546Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 249030Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134496
GnomAD4 exome AF: 0.00000898 AC: 13AN: 1448440Hom.: 1 Cov.: 30 AF XY: 0.0000125 AC XY: 9AN XY: 720072
GnomAD4 genome AF: 0.0000137 AC: 2AN: 145546Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 70668
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The c.5G>A (p.G2D) alteration is located in exon 1 (coding exon 1) of the OR4S1 gene. This alteration results from a G to A substitution at nucleotide position 5, causing the glycine (G) at amino acid position 2 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at